Dechra Pharmaceuticals PLC (DECP.L)

DECP.L on London Stock Exchange

716.00GBp
1:08pm IST
Price Change (% chg)

-7.00p (-0.97%)
Prev Close
723.00p
Open
715.50p
Day's High
719.00p
Day's Low
713.00p
Volume
6,383
Avg. Vol
80,462
52-wk High
791.50p
52-wk Low
464.50p

DECP.L

Chart for DECP.L

About

Dechra Pharmaceuticals PLC (Dechra) is a holding company. The Company operates in four segments: Product Development, European Pharmaceuticals, US Pharmaceuticals and Services. European Pharmaceuticals markets and sells pharmaceuticals and specialist pet foods to the veterinary profession in Europe. It comprises Dechra... (more)

Overall

Beta: 0.18
Market Cap (Mil.): £629.85
Shares Outstanding (Mil.): 87.12
Dividend: 4.34
Yield (%): 1.78

Financials

  DECP.L Industry Sector
P/E (TTM): 44.01 34.93 35.13
EPS (TTM): 0.16 -- --
ROI: 5.75 19.47 18.83
ROE: 10.62 20.22 19.68
Search Stocks

Dechra says profit rises 54 pct, warns of weak services sales

Feb 26 - Animal health company Dechra Pharmaceuticals Plc said its first-half pretax profit grew 54 percent, but warned that its core services unit had weak sales in January caused by a significant decline in footfall at veterinary practices.

26 Feb 2013

BRIEF-Dechra Pharmaceuticals profit rises

LONDON, Feb 26 - Dechra Pharmaceuticals PLC : * H1 underlying profit before taxation was up 46.9% to 21 million STG * H1 group revenue increased by 20.4% to 252.2 million STG * Poor sales in January at services unit on bad weather caused significant

26 Feb 2013

BRIEF-Dechra Pharma says first half in line

LONDON, Jan 8 - Dechra Pharmaceuticals PLC : * Trading across the group in the first half has been in line with management

08 Jan 2013

BRIEF-Dechra makes $15 mln contingent payment

LONDON, Nov 30 - Dechra Pharmaceuticals PLC : * Payment in the sum of $15 million (£9.4 million) has been paid to the

30 Nov 2012

Earnings vs. Estimates

Search Stocks